RYZB
RayzeBio Inc.

67
Mkt Cap
$3.74B
Volume
282,719.00
52W High
$62.51
52W Low
$17.95
Price
$62.49
RYZB Fundamentals
Prev Close
$62.48
Open
$62.49
50D MA
$61.51
Beta
2.04
Avg. Volume
224,833.45
P/B
6.50
Loading...
Loading...
Rayzebio, Inc. provides radiopharmaceutical medicines for cancer. It develops a pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225. The company was founded by Deborah Charych, Aaron Kantoff and Aron Royston in January 2020 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of RayzeBio Inc.?
What is the 52-week high for RayzeBio Inc.?
What is the 52-week low for RayzeBio Inc.?
What is RayzeBio Inc. stock price today?
What was RayzeBio Inc. stock price yesterday?
What is the Price-to-Book ratio of RayzeBio Inc.?
What is the 50-day moving average of RayzeBio Inc.?

Latest RYZB News

View

Advertisement|Remove ads.

Advertisement|Remove ads.